PillPack’s practice of under-reporting days-of-supply led its pharmacists to frequently dispense insulin pen refills significantly earlier before patients actually needed. GHPs ended up paying for more insulin pens than the exact quantity needed by patients.
In a statement, U.S. Attorney Damian Williams, said, “Pharmacies are trusted to provide accurate information to Government healthcare programs and to prevent waste when dispensing medications to patients. PillPack abused this trust by dispensing insulin refills long before patients needed them and by falsely reporting the days-of-supply of insulin actually dispensed to prevent its claims for reimbursement from being denied.”
Have a story you want USA Herald to cover? Submit a tip here and if we think it’s newsworthy, we’ll follow up on it.
Want to contribute a story? We also accept article submissions — check out our writer’s guidelines here.
